#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Paroxysmal nocturnal haemoglobinuria Pemphigoid Squamous cell carcinoma of the oral cavity Obliterative bronchiolitis Hepatitis B Retinopathy proliferative Fatty acid oxidation disorder B-cell type acute leukaemia IPEX syndrome Erythema multiforme Neuroendocrine tumour of the lung Glioblastoma Congenital ectodermal dysplasia Phenylketonuria Breast cancer metastatic More trials…

    Learn about Rare Diseases

    Cerebral arteriovenous malformation haemorrhagic – Life with Disease Ewing’s sarcoma metastatic – Basic Information Leiomyosarcoma recurrent – Treatment Advanced systemic mastocytosis – Trials in Disease Hereditary angioedema with C1 esterase inhibitor deficiency – Life with Disease Aicardi-Goutieres syndrome – Diagnostics Arterial tortuosity syndrome – Trials in Disease Usher’s syndrome – Trials in Disease Myxofibrosarcoma – Trials in Disease Atypical haemolytic uraemic syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Asundexian Cenerimod Elexacaftor Gadobutrol Hydralazine Hydrochloride Dornase Alfa Ursodeoxycholic Acid Nilutamide Blomia Tropicalis Sodium Iotalamate (125I) Glycerol Phenylbutyrate Finasteride Dosulepin Hydrochloride Fenebrutinib Corline Heparin Conjugate Anastrozole LVT-001 Ulipristal Acetate [89ZR]ZR-DFO-CIT-013 MRNA-1345 More therapies…

    Learn about Your Condition

    Mantle cell lymphoma stage II Hyperadrenocorticism Cervix carcinoma stage IV Endometrial cancer stage I Ovarian cancer stage III Ventricular extrasystoles Procedural anxiety Right ventricular dysfunction Exfoliation glaucoma Mixed-type liposarcoma Alcoholic liver disease Hypotonia Medullary thyroid cancer Cytomegalovirus infection Decreased appetite More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Early Use of Dexamethasone versus Sodium Chloride Placebo in Patients with Severe Influenza-Induced Acute Hypoxemic Respiratory Failure (Phase III Randomized Trial)

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Influenza
    • Pneumonia
    Investigated Drugs:
    • Dexamethasone Phosphate
    • Sodium Chloride
    France

  • Efficacy of asciminib in chronic phase chronic myeloid leukemia patients with T315I mutation

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Asciminib Hydrochloride
    Germany

  • Weekly Somatrogon versus Daily Somatropin in Children with Small for Gestational Age or Idiopathic Short Stature

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Short stature
    Investigated Drugs:
    • Somatropin
    Czechia France Greece Poland

  • Pharmacokinetics, Safety, and Immunogenicity of Subcutaneous Ocrelizumab in Children and Adolescents with Relapsing‑Remitting Multiple Sclerosis

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Ocrelizumab
    France Germany Poland

  • Phase IIb Open‑Label Study of Intrathecal MELPIDA (AAV9/AP4M1) in Patients with Hereditary Spastic Paraplegia Type 50 (SPG50)

    Not yet recruiting

    2 1 1
    Denmark

  • Effect of Follitropin Delta plus Menotrophin on Embryo Quality in Advanced Age Women with Infertility

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility
    • Infertility female
    Investigated Drugs:
    • Menotrophin
    • Follitropin Delta
    • Triptorelin
    Spain
Previous Page
1 … 690 691 692 693 694 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!